Core Viewpoint - Lepu Medical has officially entered the medical aesthetics field by obtaining national Class III medical device registration for three products, marking a strategic expansion beyond its core cardiovascular business [1][6]. Group 1: Product Development and Innovation - Lepu Medical has developed the "Yueyayan Tongyan Needle," a polylactic acid facial filler, which received approval from the National Medical Products Administration (NMPA) in June 2025. This product is based on a biocompatible and biodegradable material with over 20 years of research backing [6]. - The unique microsphere design of the Yueyayan product allows for precise matching of molecular weight, particle size, and morphology, making it suitable for various injection purposes and areas [6]. - The product line includes "Pearl Youth" for skin quality improvement and tightening, and "Reverse Age" for subtle volume enhancement and contour tightening, promoting collagen regeneration for gradual effects [6]. Group 2: Strategic Partnerships - Lepu Medical has signed a strategic cooperation agreement with Meituan, officially entering the platform and launching its flagship store, which will help expand its customer acquisition in the medical aesthetics sector [7]. - The collaboration aims to standardize, clarify, and regulate medical aesthetic services, creating a safer and more reliable market environment [9]. - Meituan's platform will facilitate access to quality medical resources, making aesthetic procedures more accessible and trustworthy for consumers, particularly the younger demographic [7][9]. Group 3: Business Model and Market Positioning - Lepu Medical's positioning in the medical aesthetics market emphasizes scientific and popular approaches, aiming to make aesthetic treatments more approachable for the general public [7]. - The partnership with Meituan is seen as a significant step towards building Lepu Medical's brand in the aesthetics space, leveraging Meituan's local lifestyle platform to reach a broader audience [7][9]. - The collaboration reflects a shared vision for the future of the medical aesthetics industry, focusing on safety, convenience, and consumer trust [9].